BCS and IVIVC Based on Biosimilars

 These Mainly discusses about different types of drugs and adsorption distribution metabolism excretion pathways. And This biosimilars includes, In vitro diffusion cells for dissolution testing in formulation development, The preclinical testing of ADME in INVITRO. The primary moto of this work was to suggest the biosimilars potential of biopharmaceutical classification system which are known to increase the dissolution. These insoluble drugs which is orally absorbed. These Aims at addressing all such challenges of the pharma formulation sector at biologics and biosimilars at 2019 conference. The solubility includes in biopharmaceutical classification.

 

  • In vitro drug product research
  • In vitro preclinical ADME/BCS testing
  • Dissolution testing in drug formulation
  • In vitro diffusion cells for dissolution testing in formulation development
  • Consideration of biowaiver extensions for BCS class III drugs
  • Waiver for In vivo bioavailability or bioequivalence
  • Preclinical and clinical testing for oral drug delivery

Related Conference of BCS and IVIVC Based on Biosimilars

BCS and IVIVC Based on Biosimilars Conference Speakers